Fifth Third Bancorp
LFCR icon

Fifth Third Bancorp’s Lifecore Biomedical LFCR Stock Holding History

Fifth Third Bancorp’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$781 Buy
210
+79
+60% +$545 ﹤0.01% 4151
2025
Q4 		$1.07K Hold
131
– – ﹤0.01% 2508
2025
Q3 		$964 Sell
131
-37
-22% -$280 ﹤0.01% 2532
2025
Q2 		$1.36K Buy
168
+101
+151% +$681 ﹤0.01% 2389
2025
Q1 		$472 Sell
67
-63
-48% -$392 ﹤0.01% 2451
2024
Q4 		$966 Sell
130
-90
-41% -$575 ﹤0.01% 2410
2024
Q3 		$1.08K Buy
+220
New +$1.15K ﹤0.01% 2433
2020
Q3 		– Sell
-1,000
Closed -$8K – 2324
2020
Q2 		$8K Hold
1,000
– – ﹤0.01% 1786
2020
Q1 		$9K Hold
1,000
– – ﹤0.01% 1746
2019
Q4 		$11K Hold
1,000
– – ﹤0.01% 1821
2019
Q3 		$11K Sell
1,000
-600
-38% -$6.53K ﹤0.01% 1775
2019
Q2 		$15K Buy
+1,600
New +$16.2K ﹤0.01% 1720

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return